AstraZeneca PLC ADR closed 14.68% short of its 52-week high of $87.68, which the company achieved on August 30th.
Astrazeneca is too big and complex to base its CEO's pay on the rest of the FTSE index, according to the chair of its ...
The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million ...
Pascal Soriot (pictured) topped up his basic salary of £1.8m with extras that included a bonus of £3.5m and share awards ...
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...
AstraZeneca (AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of ...
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish majority ...
UBS Group upgraded shares of AstraZeneca (NASDAQ:AZN – Free Report) from a neutral rating to a buy rating in a research note ...
A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs ...
AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results